Advances in contraception: new options for postpartum women

References

• Zhu B-P, Rolfs RT, Nangle BE, et al. Effect of the interval between pregnancies on perinatal outcomes. N Engl J Med. 1999 Feb 25;340(8):589–594.
   PubMed Web of Science ®Google Scholar
• Maternal, infant, and child health |healthy people 2020 [Internet]. [cited 2016 Dec 22]. Available from: https://www.healthypeople.gov/2020/leading-health-indicators/2020-lhi-topics/Maternal-Infant-and-Child-Health
   Google Scholar
• Conde-Agudelo A, Rosas-Bermúdez A, Kafury-Goeta AC. Effects of birth spacing on maternal health: a systematic review. Am J Obstet Gynecol. 2007 Apr;196(4):297–308.
   PubMed Web of Science ®Google Scholar
• Rigsby DC, Macones GA, Driscoll DA. Risk factors for rapid repeat pregnancy among adolescent mothers: a review of the literature. J Pediatr Adolesc Gynecol. 1998 Aug;11(3):115–126.
   PubMedGoogle Scholar
• White K, Teal SB, Potter JE. Contraception after delivery and short interpregnancy intervals among women in the United States. Obstet Gynecol. 2015 Jun;125(6):1471–1477.
   PubMed Web of Science ®Google Scholar
• Thiel de Bocanegra H, Chang R, Menz M, et al. Postpartum contraception in publicly-funded programs and interpregnancy intervals. Obstet Gynecol. 2013 Aug;122(2 Pt 1):296–303.
   PubMed Web of Science ®Google Scholar
• Rodriguez MI, Chang R, Thiel De Bocanegra H. The impact of postpartum contraception on reducing preterm birth: findings from California. Am J Obstet Gynecol. 2015 Nov;213(5):703.e1–6.
   PubMed Web of Science ®Google Scholar
• Trussell J. Contraceptive failure in the United States. Contraception. 2011 May;83(5):397–404.
   PubMed Web of Science ®Google Scholar
• Thiel de Bocanegra H, Chang R, Howell M, et al. Interpregnancy intervals: impact of postpartum contraceptive effectiveness and coverage. Am J Obstet Gynecol. 2014 Apr;210(4):311.e1–8.
   PubMed Web of Science ®Google Scholar
• Harney C, Dude A, Haider S. Factors associated with short interpregnancy interval in women who plan postpartum LARC: a retrospective study. Contraception. 2016 Aug 30;95:245–250.
   PubMedGoogle Scholar
• Baldwin MK, Edelman AB. The effect of long-acting reversible contraception on rapid repeat pregnancy in adolescents: a review. J Adolesc Health Off Publ Soc Adolesc Med. 2013 Apr;52(4 Suppl):S47–53.
   Google Scholar
• Hatcher R, Trussell J, Nelson AL, et al. Contraceptive Technology. 20th ed. Atlanta (GA): Bridging the Gap Communications; 2011. p. 906.
   Google Scholar
• Stuart JE, Secura GM, Zhao Q, et al. Factors associated with 12-month discontinuation among contraceptive pill, patch, and ring users. Obstet Gynecol. 2013 Feb;121(2 Pt 1):330–336.
   PubMed Web of Science ®Google Scholar
• White K, Potter JE, Hopkins K, et al. Variation in postpartum contraceptive method use: results from the Pregnancy Risk Assessment Monitoring System (PRAMS). Contraception. 2014 Jan;89(1):57–62.
   PubMed Web of Science ®Google Scholar
• Zerden ML, Tang JH, Stuart GS, et al. Barriers to receiving long-acting reversible contraception in the postpartum period. Womens Health Issues Off Publ Jacobs Inst Womens Health. 2015 Dec;25(6):616–621.
   PubMed Web of Science ®Google Scholar
• Committee opinion no. 666: optimizing postpartum care. Obstet Gynecol. 2016 Jun;127(6):e187–92.
   PubMed Web of Science ®Google Scholar
• Gray RH, Campbell OM, Zacur HA, et al. Postpartum return of ovarian activity in nonbreastfeeding women monitored by urinary assays. J Clin Endocrinol Metab. 1987;64(4):645–650. .
   PubMed Web of Science ®Google Scholar
• Sok C, Sanders JN, Saltzman HM, et al. Sexual behavior, satisfaction, and contraceptive use among postpartum women. J Midwifery Womens Health. 2016 Apr;61(2):158–165.
   PubMed Web of Science ®Google Scholar
• Delvoye P, Demaegd M, Uwayitu-Nyampeta RC. Serum prolactin, gonadotropins, and estradiol in menstruating and amenorrheic mothers during two years’ lactation. Am J Obstet Gynecol. 1978 Mar 15;130(6):635–639.
   PubMed Web of Science ®Google Scholar
• Van der Wijden C, Manion C. Lactational amenorrhoea method for family planning. Cochrane Database Syst Rev. 2015 Oct;12(10):CD001329.
   Google Scholar
• Labbok MH, Hight-Laukaran V, Peterson AE, et al. Multicenter study of the Lactational Amenorrhea Method (LAM): I. Efficacy, duration, and implications for clinical application. Contraception. 1997 Jun 1;55(6):327–336.
   PubMed Web of Science ®Google Scholar
• Gray RH, Campbell OM, Apelo R, et al. Risk of ovulation during lactation. The Lancet. 1990 Jan 6;335(8680):25–29.
   PubMed Web of Science ®Google Scholar
• Campbell OM, Gray RH. Characteristics and determinants of postpartum ovarian function in women in the United States. Am J Obstet Gynecol. 1993 Jul;169(1):55–60.
   PubMed Web of Science ®Google Scholar
• Curtis KM, Tepper NK, Jatlaoui TC, et al. U.S. medical eligibility criteria for contraceptive use, 2016. MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep Cent Dis Control. 2016;65(3):1–103.
   PubMedGoogle Scholar
• James AH, Tapson VF, Goldhaber SZ. Thrombosis during pregnancy and the postpartum period. Am J Obstet Gynecol. 2005 Jul;193(1):216–219.
   PubMed Web of Science ®Google Scholar
• Heit JA, Kobbervig CE, James AH, et al. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med. 2005 Nov 15;143(10):697–706.
   PubMed Web of Science ®Google Scholar
• Salonen Ros H, Lichtenstein P, Bellocco R, et al. Increased risks of circulatory diseases in late pregnancy and puerperium. Epidemiol Camb Mass. 2001 Jul;12(4):456–460.
   PubMed Web of Science ®Google Scholar
• Pomp ER, Lenselink AM, Rosendaal FR, et al. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost JTH. 2008 Apr;6(4):632–637.
   PubMed Web of Science ®Google Scholar
• Jacobsen AF, Skjeldestad FE, Sandset PM. Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium–a register-based case-control study. Am J Obstet Gynecol. 2008 Feb;198(2):233.e1–7.
   PubMed Web of Science ®Google Scholar
• Helmerhorst FM, Rosendaal FR, Vandenbroucke JP. Venous thromboembolism and the pill. The WHO technical report on cardiovascular disease and steroid hormone contraception: state-of-the-art. World Health Organization Hum Reprod Oxf Engl. 1998 Nov;13(11):2981–2983.
   PubMed Web of Science ®Google Scholar
• Lidegaard Ø, Løkkegaard E, Svendsen AL, et al. Hormonal contraception and risk of venous thromboembolism: national follow-up study. Bmj. 2009 Aug 13;339:b2890.
   PubMed Web of Science ®Google Scholar
• Sidney S, Petitti DB, Soff GA, et al. Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptives. Contraception. 2004 Jul;70(1):3–10.
   PubMed Web of Science ®Google Scholar
• Vandenbroucke JP, Rosing J, Bloemenkamp KW, et al. Oral contraceptives and the risk of venous thrombosis. N Engl J Med. 2001 May 17;344(20):1527–1535.
   PubMed Web of Science ®Google Scholar
• Contraception WHOCS of CD and SH. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives: results of an international, multicenter, case-control study. Contraception. 1998 May;57(5):315–324.
   PubMed Web of Science ®Google Scholar
• Baldwin MK, Edelman AB, Lim JY, et al. Intrauterine device placement at 3 versus 6 weeks postpartum: a randomized trial. Contraception. 2016 Apr;93(4):356–363.
   PubMed Web of Science ®Google Scholar
• Zerden ML, Stuart GS, Charm S, et al. Two-week postpartum intrauterine contraception insertion: a study of feasibility, patient acceptability and short-term outcomes. Contraception. 2016 Aug 20;95(1):65–70.
   PubMed Web of Science ®Google Scholar
• Glazer AB, Wolf A, Gorby N. Postpartum contraception: needs vs. reality. Contraception. 2011 Mar;83(3):238–241.
   PubMed Web of Science ®Google Scholar
• Committee opinion no. 670: immediate postpartum long-acting reversible contraception. Obstet Gynecol. 2016 Aug;128(2):e32–7.
   PubMed Web of Science ®Google Scholar
• Lopez LM, Bernholc A, Hubacher D, et al. Immediate postpartum insertion of intrauterine device for contraception. Cochrane Database Syst Rev. 2015;6:CD003036.
   Google Scholar
• Levi EE, Stuart GS, Zerden ML, et al. Intrauterine device placement during cesarean delivery and continued use 6 months postpartum: a randomized controlled trial. Obstet Gynecol. 2015 Jul;126(1):5–11.
   PubMed Web of Science ®Google Scholar
• Lester F, Kakaire O, Byamugisha J, et al. Intracesarean insertion of the copper T380A versus 6 weeks postcesarean: a randomized clinical trial. Contraception. 2015 Mar;91(3):198–203.
   PubMed Web of Science ®Google Scholar
• Braniff K, Gomez E, Muller R. A randomised clinical trial to assess satisfaction with the levonorgestrel- releasing intrauterine system inserted at caesarean section compared to postpartum placement. Aust N Z J Obstet Gynaecol. 2015 Jun;55(3):279–283.
   PubMed Web of Science ®Google Scholar
• Whitaker AK, Endres LK, Mistretta SQ, et al. Postplacental insertion of the levonorgestrel intrauterine device after cesarean delivery vs. delayed insertion: a randomized controlled trial. Contraception. 2014 Jun;89(6):534–539.
   PubMed Web of Science ®Google Scholar
• Dahlke JD, Terpstra ER, Ramseyer AM, et al. Postpartum insertion of levonorgestrel–intrauterine system at three time periods: a prospective randomized pilot study. Contraception. 2011 Sep;84(3):244–248.
   PubMed Web of Science ®Google Scholar
• Chen BA, Reeves MF, Hayes JL, et al. Postplacental or delayed insertion of the levonorgestrel intrauterine device after vaginal delivery. Obstet Gynecol. 2010 Nov;116(5):1079–1087.
   PubMed Web of Science ®Google Scholar
• Nelson AL, Chen S, Eden R. Intraoperative placement of the copper T-380 intrauterine devices in women undergoing elective cesarean delivery: a pilot study. Contraception. 2009 Jul;80(1):81–83.
   PubMed Web of Science ®Google Scholar
• Elsedeek MSE. Puerperal and menstrual bleeding patterns with different types of contraceptive device fitted during elective cesarean delivery. Int J Gynecol Obstet. 2012 Jan;116(1):31–34.
   PubMed Web of Science ®Google Scholar
• Çelen Ş, Sucak A, Yıldız Y, et al. Immediate postplacental insertion of an intrauterine contraceptive device during cesarean section. Contraception. 2011 Sep;84(3):240–243.
   PubMed Web of Science ®Google Scholar
• Levi E, Cantillo E, Ades V, et al. Immediate postplacental IUD insertion at cesarean delivery: a prospective cohort study. Contraception. 2012 Aug;86(2):102–105.
   PubMed Web of Science ®Google Scholar
• Stuart GS, Bryant AG, O’Neill E, et al. Feasibility of postpartum placement of the levonorgestrel intrauterine system more than 6 h after vaginal birth. Contraception. 2012 Apr;85(4):359–362.
   PubMed Web of Science ®Google Scholar
• Stuart GS, Lesko CR, Stuebe AM, et al. A randomized trial of levonorgestrel intrauterine system insertion 6 to 48 h compared to 6 weeks after vaginal delivery; lessons learned. Contraception. 2015 Apr;91(4):284–288.
   PubMed Web of Science ®Google Scholar
• Eroğlu K, Akkuzu G, Vural G, et al. Comparison of efficacy and complications of IUD insertion in immediate postplacental/early postpartum period with interval period: 1 year follow-up. Contraception. 2006 Nov;74(5):376–381.
   PubMed Web of Science ®Google Scholar
• Bryant AG, Kamanga G, Stuart GS, et al. Immediate postpartum versus 6-week postpartum intrauterine device insertion: a feasibility study of a randomized controlled trial. Afr J Reprod Health. 2013 Jun;17(2):72–79.
   PubMedGoogle Scholar
• Woo I, Seifert S, Hendricks D, et al. Six-month and 1-year continuation rates following postpartum insertion of implants and intrauterine devices. Contraception. 2015 Dec;92(6):532–535.
   PubMed Web of Science ®Google Scholar
• Ireland LD, Goyal V, Raker CA, et al. The effect of immediate postpartum compared to delayed postpartum and interval etonogestrel contraceptive implant insertion on removal rates for bleeding. Contraception. 2014 Sep;90(3):253–258.
   PubMed Web of Science ®Google Scholar
• Guazzelli CAF, de Queiroz FT, Barbieri M, et al. Etonogestrel implant in postpartum adolescents: bleeding pattern, efficacy and discontinuation rate. Contraception. 2010 Sep;82(3):256–259.
   PubMed Web of Science ®Google Scholar
• Cohen R, Sheeder J, Arango N, et al. Twelve-month contraceptive continuation and repeat pregnancy among young mothers choosing postdelivery contraceptive implants or postplacental intrauterine devices. Contraception. 2016 Feb;93(2):178–183.
   PubMed Web of Science ®Google Scholar
• Bryant AG, Bauer AE, Stuart GS, et al. Etonogestrel-releasing contraceptive implant for postpartum adolescents: a randomized controlled trial. J Pediatr Adolesc Gynecol. 2016 Aug 22. Forthcoming.
   Google Scholar
• Wilson S, Tennant C, Sammel MD, et al. Immediate postpartum etonogestrel implant: a contraception option with long-term continuation. Contraception. 2014 Sep;90(3):259–264.
   PubMed Web of Science ®Google Scholar
• Hooda R, Mann S, Nanda S, et al. Immediate postpartum intrauterine contraceptive device insertions in caesarean and vaginal deliveries: a comparative study of follow-up outcomes. Int J Reprod Med. 2016;2016:7695847.
   PubMedGoogle Scholar
• Thurman AR, Hammond N, Brown HE, et al. Preventing repeat teen pregnancy: postpartum depot medroxyprogesterone acetate, oral contraceptive pills, or the patch? J Pediatr Adolesc Gynecol. 2007 Apr;20(2):61–65.
   PubMed Web of Science ®Google Scholar
• Templeman CL, Cook V, Goldsmith LJ, et al. Postpartum contraceptive use among adolescent mothers. Obstet Gynecol. 2000 May;95(5):770–776.
   PubMed Web of Science ®Google Scholar
• Triebwasser JE, Higgins S, Secura GM, et al. Pharmacy claims data versus patient self-report to measure contraceptive method continuation. Contraception. 2015 Jul;92(1):26–30.
   PubMed Web of Science ®Google Scholar
• Nelson AL, Westhoff C, Schnare SM. Real-world patterns of prescription refills for branded hormonal contraceptives: a reflection of contraceptive discontinuation. Obstet Gynecol. 2008 Oct;112(4):782–787.
   PubMed Web of Science ®Google Scholar
• Diedrich JT, Zhao Q, Madden T, et al. Three-year continuation of reversible contraception. Am J Obstet Gynecol. 2015 Nov;213(5):662.e1–8.
   Web of Science ®Google Scholar
• Casey PM, Long ME, Marnach ML, et al. Bleeding related to etonogestrel subdermal implant in a US population. Contraception. 2011 May;83(5):426–430.
   PubMed Web of Science ®Google Scholar
• Lewis LN, Doherty DA, Hickey M, et al. Implanon as a contraceptive choice for teenage mothers: a comparison of contraceptive choices, acceptability and repeat pregnancy. Contraception. 2010 May;81(5):421–426.
   PubMed Web of Science ®Google Scholar
• Brito MB, Ferriani RA, Quintana SM, et al. Silva de Sá MF, Vieira CS. Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study. Contraception. 2009 Dec;80(6):519–526.
   PubMed Web of Science ®Google Scholar
• Heinemann K, Reed S, Moehner S, et al. Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European active surveillance study on intrauterine devices. Contraception. 2015 Apr;91(4):274–279.
   PubMed Web of Science ®Google Scholar
• Walsh T, Grimes D, Frezieres R, et al. Randomised controlled trial of prophylactic antibiotics before insertion of intrauterine devices. IUD Study Group Lancet Lond Engl. 1998 Apr 4;351(9108):1005–1008.
   PubMed Web of Science ®Google Scholar
• Farley TM, Rosenberg MJ, Rowe PJ, et al. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet Lond Engl. 1992 Mar 28;339(8796):785–788.
   PubMed Web of Science ®Google Scholar
• International planned parenthood Federation IPPF. International Medical Advisory Panel IMAP. New IPPF statement on breastfeeding, fertility and post-partum contraception. IPPF Med Bull. 1990 Apr;24(2):2–4.
   PubMedGoogle Scholar
• Kaern T. Effect of an oral contraceptive immediately post partum on initiation of lactation. Br Med J. 1967 Sep 9;3(5566):644–645.
   PubMed Web of Science ®Google Scholar
• Miller GH, Hughes LR. Lactation and genital involution effects of a new low-dose oral contraceptive on breast-feeding mothers and their infants. Obstet Gynecol. 1970 Jan;35(1):44–50.
   PubMed Web of Science ®Google Scholar
• Croxatto HB, Díaz S, Peralta O, et al. Fertility regulation in nursing women: IV. Long-term influence of a low-dose combined oral contraceptive initiated at day 30 postpartum upon lactation and infant growth. Contraception. 1983 Jan;27(1):13–25.
   PubMed Web of Science ®Google Scholar
• Peralta O, Díaz S, Juez G, et al. Fertility regulation in nursing women: V. Long-term influence of a low-dose combined oral contraceptive initiated at day 90 postpartum upon lactation and infant growth. Contraception. 1983 Jan;27(1):27–38.
   PubMed Web of Science ®Google Scholar
• Díaz S, Peralta O, Juez G, et al. Fertility regulation in nursing women: III. Short-term influence of a low-dose combined oral contraceptive upon lactation and infant growth. Contraception. 1983 Jan;27(1):1–11.
   PubMed Web of Science ®Google Scholar
• Gambrell RD. Immediate postpartum oral contraception. Obstet Gynecol. 1970 Jul;36(1):101–106.
   PubMed Web of Science ®Google Scholar
• Tankeyoon M, Dusitsin N, Chalapati S, et al. Effects of hormonal contraceptives on milk volume and infant growth. WHO special programme of research, development and research training in human reproduction task force on oral contraceptives. Contraception. 1984 Dec;30(6):505–522.
   PubMedGoogle Scholar
• Nilsson S, Mellbin T, Hofvander Y, et al. Long-term follow-up of children breast-fed by mothers using oral contraceptives. Contraception. 1986 Nov;34(5):443–457.
   PubMed Web of Science ®Google Scholar
• Effects of hormonal contraceptives on breast milk composition and infant growth. World Health Organization (WHO) Task Force on Oral Contraceptives. Stud Fam Plann. 1988 Dec;19(6 Pt 1):361–369.
   PubMed Web of Science ®Google Scholar
• Kamal I, Hefnawi F, Ghoneim M, et al. Clinical, biochemical, and experimental studies on lactation. II. Clinical effects of gestagens on lactation. Am J Obstet Gynecol. 1969 Oct 1;105(3):324–334.
   PubMed Web of Science ®Google Scholar
• Espey E, Ogburn T, Leeman L, et al. Effect of progestin compared with combined oral contraceptive pills on lactation: a randomized controlled trial. Obstet Gynecol. 2012 Jan;119(1):5–13.
   PubMed Web of Science ®Google Scholar
• Bahamondes L, Bahamondes MV, Modesto W, et al. Effect of hormonal contraceptives during breastfeeding on infant’s milk ingestion and growth. Fertil Steril. 2013 Aug;100(2):445–450.
   PubMed Web of Science ®Google Scholar
• Progestogen-only contraceptives during lactation: I. Infant growth. World Health Organization task force for epidemiological research on reproductive health; special programme of research, development and research training in human reproduction. Contraception. 1994 Jul;50(1):35–53.
   PubMedGoogle Scholar
• Progestogen-only contraceptives during lactation: II. Infant development. World Health Organization, task force for epidemiological research on reproductive health; special programme of research, development, and research training in human reproduction. Contraception. 1994 Jul;50(1):55–68.
   PubMedGoogle Scholar
• Halderman LD, Nelson AL. Impact of early postpartum administration of progestin-only hormonal contraceptives compared with nonhormonal contraceptives on short-term breast-feeding patterns. Am J Obstet Gynecol. 2002 Jun;186(6):1250–6; discussion 1256–8.
   PubMed Web of Science ®Google Scholar
• Kapp N, Curtis K, Nanda K. Progestogen-only contraceptive use among breastfeeding women: a systematic review. Contraception. 2010 Jul;82(1):17–37.
   PubMed Web of Science ®Google Scholar
• Phillips SJ, Tepper NK, Kapp N, et al. Progestogen-only contraceptive use among breastfeeding women: a systematic review. Contraception. 2016 Sep;94(3):226–252.
   PubMed Web of Science ®Google Scholar
• Goldstuck ND, Steyn PS. Intrauterine contraception after cesarean section and during lactation: a systematic review. Int J Womens Health. 2013;5:811–818.
   PubMedGoogle Scholar
• Shaamash AH, Sayed GH, Hussien MM, et al. A comparative study of the levonorgestrel-releasing intrauterine system Mirena® versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development. Contraception. 2005 Nov;72(5):346–351.
   PubMed Web of Science ®Google Scholar
• Braga GC, Ferriolli E, Quintana SM, et al. Immediate postpartum initiation of etonogestrel-releasing implant: A randomized controlled trial on breastfeeding impact. Contraception. 2015 Dec;92(6):536–542.
   PubMed Web of Science ®Google Scholar
• Gurtcheff SE, Turok DK, Stoddard G, et al. Lactogenesis after early postpartum use of the contraceptive implant: a randomized controlled trial. Obstet Gynecol. 2011 May;117(5):1114–1121.
   PubMed Web of Science ®Google Scholar
• Jackson E, Glasier A. Return of ovulation and menses in postpartum nonlactating women: a systematic review. Obstet Gynecol. 2011 Mar;117(3):657–662.
   PubMed Web of Science ®Google Scholar
• Singal S, Bharti R, Dewan R, et al. Clinical outcomes of postplacental Cooper T 380A insertion in women delivering by cesarean section. Clin Diagn Res. 2014 Sep;8(9):OC01–04.
   PubMedGoogle Scholar
• Hayes JL, Cwiak C, Goedken P, et al. A pilot clinical trial of ultrasound-guided postplacental insertion of a levonorgestrel intrauterine device. Contraception. 2007 Oct;76(4):292–296.
   PubMed Web of Science ®Google Scholar
• Celen S, Moroy P, Sucak A, et al. Clinical outcomes of early postplacental insertion of intrauterine contraceptive devices. Contraception. 2004 Apr;69(4):279–282.
   PubMed Web of Science ®Google Scholar
• Brownell EA, Fernandez DI, Fisher SG, et al. The effect of immediate postpartum depot medroxyprogesterone on early breastfeeding cessation. Contraception. 2013 Jun;87(6):836–843.
   PubMed Web of Science ®Google Scholar